+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Are progranulin levels associated with polycystic ovary syndrome and its possible metabolic effects in adolescents and young women?



Are progranulin levels associated with polycystic ovary syndrome and its possible metabolic effects in adolescents and young women?



Archives of Gynecology and Obstetrics 294(2): 403-409



Polycystic ovary syndrome (PCOS) is an important disease that may alter metabolic balances of the whole body. Progranulin is a growth factor which is related to epithelial, neuronal growth and oogenesis. Here, we aimed to investigate the diagnostic value of the levels of Progranulin in the clinical setting of PCOS, and its metabolic effects. Forty-one adolescents and young women with PCOS and 39 age and body mass index matched adolescents and young women as a control group who attended to the youth center of a tertiary referral center were included in this cross-sectional case-control study. Progranulin levels, indices of insulin sensitivity, lipidemic markers, metabolic syndrome (MetS) criteria were compared between the groups. Progranulin levels in patients with PCOS (7.48 ± 1.93 ng/mL) were significantly higher than in the control group (6.25 ± 1.98 ng/mL) (p = 0.006). Luteinizing hormone (LH) levels, LH/Follicle stimulating hormone (FSH) ratios, free testosterone, dehydroepiandrosterone sulfate (DHEAS), C-reactive protein (CRP) levels in patients with PCOS were significantly higher than in the control group (p < 0.05, for all). The MetS was present in 8 (19.5 %) of the patients in the study group and in 1 (2.3 %) of the patients in the control group (p = 0.029). There was significant inverse correlation between high-density lipoprotein cholesterol (HDL-C) and progranulin levels of patients diagnosed with PCOS (p = 0.008). Progranulin may be a novel biomarker for cardiovascular risk in patients with PCOS, thus these cases should be directed to close follow-up for possible cardiovascular diseases. Future larger studies should focus on this entity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057230086

Download citation: RISBibTeXText

PMID: 27071619

DOI: 10.1007/s00404-016-4096-8


Related references

Do the Anti-Müllerian Hormone Levels of Adolescents with Polycystic Ovary Syndrome, Those Who Are at Risk for Developing Polycystic Ovary Syndrome, and Those Who Exhibit Isolated Oligomenorrhea Differ from Those of Adolescents with Normal Menstrual Cycles?. Hormone Research in Paediatrics 85(6): 406-411, 2017

Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome. Journal of Family and Reproductive Health 9(4): 172-176, 2016

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clinical Endocrinology 66(4): 513-517, 2007

Frequency and risk factors for metabolic syndrome in adolescents and adults women with polycystic ovary syndrome. Revista Brasileira de Ginecologia E Obstetricia 34(8): 357-361, 2013

Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit?. Journal of Clinical Endocrinology and Metabolism 85(10): 3520-3525, 2000

Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pacific Journal of Clinical Nutrition 21(4): 511-518, 2012

The metabolic syndrome in young Korean women with polycystic ovary syndrome. Diabetes Research and Clinical Practice 77 Suppl 1: S243-S246, 2007

Metabolic syndrome in young Czech women with polycystic ovary syndrome. Human Reproduction 20(12): 3328-3332, 2005

Metabolic effects of polycystic ovary syndrome in adolescents. Annals of Pediatric Endocrinology and Metabolism 20(3): 136-142, 2015

Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Human Reproduction 20(9): 2409-2413, 2005

Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Hormones and Behavior 51(5): 587-596, 2007

High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Gynecological Endocrinology 30(11): 781-784, 2015

Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Fertility and Sterility 90(4): 1139-1143, 2007

Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. Gynecological Endocrinology 29(6): 551-555, 2014

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clinical Endocrinology 50(4): 517-527, 1999